FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells

Journal of Cellular Physiology

Volumn 203, Issue 2, 2005, Pages 398-409

  Solchaga, Luis A ^a,b   Penick, Kitsie ^a   Porter, John D ^a   Goldberg, Victor M ^a   Caplan, Arnold I ^a   Welter, Jean F ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; CYTOKINE; FIBROBLAST GROWTH FACTOR 2;

ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MITOSIS; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

AGE FACTORS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; COLLAGEN; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STEM CELLS; MITOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOGLYCANS; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; UP-REGULATION;

ANGUILLIFORMES;

EID: 16344377055     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20238     Document Type: Article

References (60)

1. Abeyta MJ, Clark AT, Rodriguez RT, Bodnar MS, Pera RA, Firpo MT. 2004. Unique gene expression signatures of independently-derived human embryonic stem cell lines. Hum Mol Genet 13(6):601-608.
2. Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z, Deng JM, Taketo MM, Nakamura T, Behringer RR, McCrea PD, de Crombrugghe B. 2004. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 18(9):1072-1087.
3. Ballock RT, Reddi AH. 1994. Thyroxine is the serum factor that regulates morphogenesis of columnar cartilage from isolated chondrocytes in chemically defined medium. J Cell Biol 126(5):1311-1318.
4. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. 2000. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol 28(6):707-715.
5. Banfi A, Bianchi G, Notaro R, Luzzatto L, Cancedda R, Quarto R. 2002. Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng 8(6):901-910.
6. Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R, Quarto R. 2003. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 287(1):98-105.
7. Bruder SP, Jaiswal N, Haynesworth SE. 1997. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64(2):278-294.
8. Caplan AI. 1994. The mesengenic process. Clin Plast Surg 21(3):429-435.
9. Carrino DA, Arias JL, Caplan AI. 1991. A spectrophotometric modification of a sensitive densitometric Safranin O assay for glycosaminoglycans. Biochem Int 24(3):485-495.
10. Chang SH, Oh CD, Yang MS, Kang SS, Lee YS, Sonn JK, Chun JS. 1998. Protein kinase C regulates chondrogenesis of mesenchymes via mitogen-activated protein kinase signaling. J Biol Chem 273(30):19213-19219.
11. Church V, Nohno T, Linker C, Marcelle C, Francis-West P. 2002. Wnt regulation of chondrocyte differentiation. J Cell Sci 115(Pt 24):4809-4818.
12. Conget PA, Minguell JJ. 1999. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181(1):67-73.
13. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. 1999. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107(2):275-281.
14. Fischer L, Boland G, Tuan RS. 2002. Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J Cell Biochem 84(4):816-831.
15. Friedenstein AJ. 1976. Precursor cells of mechanocytes. Int Rev Cytol 47:327-359.
16. Grotewold L, Ruther U. 2002. Bmp, Fgf, and Wnt signalling in programmed cell death and chondrogenesis during vertebrate limb development: The role of Dickkopf-1. Int J Dev Biol 46(7):943-947.
17. Hartmann C, Tabin CJ. 2000. Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development 127(14):3141-3159.
18. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. 1992. Characterization of cells with osteogenic potential from human bone marrow. Bone 13:81-88.
19. Hoffman LM, Weston AD, Underbill TM. 2003. Molecular mechanisms regulating chondroblast differentiation. J Bone Joint Surg Am 85-A(Suppl 2):124-132.
20. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31(4):e15.
21. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. 1998. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238(1):265-272.
22. Kawakami Y, Wada N, Nishimatsu SI, Ishikawa T, Noji S, Nohno T. 1999. Involvement of Wnt-5a in chondrogenic pattern formation in the chick limb bud. Dev Growth Differ 41(1):29-40.
23. Khanna S, Merriam AP, Gong B, Leahy P, Porter JD. 2003. Comprehensive expression profiling by muscle tissue class and identification of the molecular niche of extraocular muscle. FASEB J 17(10):1370-1372.
24. Kovalenko D, Yang X, Nadeau RJ, Harkins LK, Friesel R. 2003. Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation. J Biol Chem 278(16):14087-14091.
25. Lagasse E, Shizuru JA, Uchida N, Tsukamoto A, Weissman IL. 2001. Toward regenerative medicine. Immunity 14(4):425-436.
26. Lee SJ, Jeon HB, Lee JH, Yoo JS, Chun JS, Yoo YJ. 2004. Identification of proteins differentially expressed during chondrogenesis of mesenchymal cells. FEBS Lett 563(1-3):35-40.
27. Lennon DP, Haynesworth SE, Bruder SP, Jaiswal N, Caplan AI. 1996. Human and animal mesenchymal progenitor cells from bone marrow: Identification of serum for optimal selection and proliferation. In Vitro Cell Dev Biol 32(10):602-611.
28. Lim YB, Kang SS, An WG, Lee YS, Chun JS, Sonn JK. 2003. Chondrogenesis induced by actin cytoskeleton disruption is regulated via protein kinase C-dependent p38 mitogen-activated protein kinase signaling. J Cell Biochem 88(4):713-718.
29. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. 1998. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4(4):415-428.
30. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R. 1997. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138(10):4456-4462.
31. Mastrogiacomo M, Cancedda R, Quarto R. 2001. Effect of different growth factors on the chondrogenic potential of human bone marrow stromal cells. Osteoarthritis Cartilage 9(Suppl A):S36-S40.
32. Minguell JJ, Erices A, Conget P. 2001. Mesenchymal stem cells. Exp Biol Med (Maywood) 226(6):507-520.
33. Nakamura K, Shirai T, Morishita S, Uchida S, Saeki-Miura K, Makishima F. 1999. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp Cell Res 250(2):351-363.
34. Owen M. 1988. Marrow stromal stem cells. J Cell Sci Suppl 10:63-76.
35. Owen M, Friedenstein AJ. 1988. Stromal stem cells: Marrow-derived osteogenic precursors. Ciba Found Symp 136:42-60.
36. Phinney DG, Kopen G, Righter W, Webster S, Tremain N, Prockop DJ. 1999. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75(3):424-436.
37. Pittenger MF, Mbalaviele G, Black M, Mosca JD, Marshak DR. 2001. Mesenchymal stem cells. In: Koller MR, Palsson BO, Masters JRW, editors. Primary mesenchymal cells. Dordrecht; Boston: Kluwer Academic Publishers. pp 189-207.
38. Ponticiello MS, Schinagl RM, Kadiyala S, Barry FP. 2000. Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J Biomed Mater Res 52(2):246-255.
39. Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, Leahy P, Li J, Andrade FH. 2001. Extraocular muscle is defined by a fundamentally distinct gene expression profile. Proc Natl Acad Sci USA 98(21): 12062-12067.
40. Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, Leahy P, Li J, Guo W, Andrade FH. 2002. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 11:263-272.
41. Porter JD, Leahy P, Khanna S, Cheng G, Veigl ML. 2003a. Applicability and practice of genome-wide expression profililng: Insights from studies of skeletal muscle diversity and disease mechanisms. In: Appasani K, editor. Perspectives in gene expression. Westboro, MA: Eaton Publishing. pp 221-244.
42. Porter JD, Merriam AP, Khanna S, Andrade FH, Richmonds CR, Leahy P, Cheng G, Karathanasis P, Zhou X, Kusner LL, Adams ME, Willem M, Mayer U, Kaminski HJ. 2003b. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice. FASEB J 17(8): 893-895.
43. Porter JD, Merriam AP, Leahy P, Gong B, Khanna S. 2003c. Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. Hum Mol Genet 12(15):1813-1821.
44. Rudnicki JA, Brown AM. 1997. Inhibition of chondrogenesis by Wnt gene expression in vivo and in vitro. Dev Biol 185(1):104-118.
45. Seghatoleslami MR, Roman-Blas JA, Rainville AM, Modaressi R, Danielson KG, Tuan RS. 2003. Progression of chondrogenesis in C3H10T1/2 cells is associated with prolonged and tight regulation of ERK1/2. J Cell Biochem 88(6):1129-1144.
46. Shea CM, Edgar CM, Einhorn TA, Gerstenfeld LC. 2003. BMP treatment of C3H10T1/2 mesenchymal stem cells induces both chondrogenesis and osteogenesis. J Cell Biochem 90(6):1112-1127.
47. Silva WA, Jr., Covas DT, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL, Santos AR, Zago MA. 2003. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 21(6):661-669.
48. Smith AG. 2001. Embryo-derived stem cells: Of mice and men. Annu Rev Cell Dev Biol 17:435-462.
49. Stanton LA, Underbill TM, Beier F. 2003. MAP kinases in chondrocyte differentiation. Dev Biol 263(2):165-175.
50. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, Takagishi K, Kato Y. 2001. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288(2):413-419.
51. Tuan RS. 2003. Cellular signaling in developmental chondrogenesis: N-cadherin, Wnts, and BMP-2. J Bone Joint Surg Am 85-A(Suppl 2):137-141.
52. Tufan AC, Tuan RS. 2001. Wnt regulation of limb mesenchymal chondrogenesis is accompanied by altered N-cadherin-related functions. FASEB J 15(8):1436-1438.
53. Tufan AC, Daumer KM, Tuan RS. 2002. Frizzled-7 and limb mesenchymal chondrogenesis: Effect of misexpression and involvement of N-cadherin. Dev Dyn 223(2):241-253.
54. Tuli R, Seghatoleslami MR, Tuli S, Howard MS, Danielson KG, Tuan RS. 2002. p38 MAP kinase regulation of AP-2 binding in TGF-beta1-stimulated chondrogenesis of human trabecular bone-derived cells. Ann NY Acad Sci 961:172-177.
55. Tuli R, Tuli S, Nandi S, Huang X, Manner PA, Hozack WJ, Danielson KG, Hall DJ, Tuan RS. 2003. Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem 278(42): 41227-41236.
56. Watanabe H, de Caestecker MP, Yamada Y. 2001. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 276(17):14466-14473.
57. Weston AD, Sampaio AV, Ridgeway AG, Underhill TM. 2003. Inhibition of p38 MAPK signaling promotes late stages of myogenesis. J Cell Sci 116(Pt 14): 2885-2893.
58. Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, Johnstone B. 1998. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80(12):1745-1757.
59. Yoon YM, Kim SJ, Oh CD, Ju JW, Song WK, Yoo YJ, Huh TL, Chun JS. 2002. Maintenance of differentiated phenotype of articular chondrocytes by protein kinase C and extracellular signal-regulated protein kinase. J Biol Chem 277(10):8412-8420.
60. Zhou S, Eid K, Glowacki J. 2004. Cooperation between TFG-beta and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells. J Bone Miner Res 19(3):463-470.